176 related articles for article (PubMed ID: 33283412)
1. In vitro and in vivo comparative performance studies of gadolinium-loaded zeolites and Gd-DOTA as contrast agents for MRI applications.
Contro J; Silva DA; Santisteban OAN; Narayana PA; Nery JG
J Biomed Mater Res B Appl Biomater; 2021 Aug; 109(8):1105-1115. PubMed ID: 33283412
[TBL] [Abstract][Full Text] [Related]
2. A new biodegradable and biocompatible gadolinium (III) -polymer for liver magnetic resonance imaging contrast agent.
Xiao Y; Xue R; You T; Li X; Pei F
Magn Reson Imaging; 2015 Jul; 33(6):822-8. PubMed ID: 25839395
[TBL] [Abstract][Full Text] [Related]
3. Gadolinium MRI contrast agents based on triazine dendrimers: relaxivity and in vivo pharmacokinetics.
Lim J; Turkbey B; Bernardo M; Bryant LH; Garzoni M; Pavan GM; Nakajima T; Choyke PL; Simanek EE; Kobayashi H
Bioconjug Chem; 2012 Nov; 23(11):2291-9. PubMed ID: 23035964
[TBL] [Abstract][Full Text] [Related]
4. First in vivo MRI assessment of a self-assembled metallostar compound endowed with a remarkable high field relaxivity.
Livramento JB; Weidensteiner C; Prata MI; Allegrini PR; Geraldes CF; Helm L; Kneuer R; Merbach AE; Santos AC; Schmidt P; Tóth E
Contrast Media Mol Imaging; 2006; 1(1):30-9. PubMed ID: 17193598
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics and biodistribution study of self-assembled Gd-micelles demonstrating blood-pool contrast enhancement for MRI.
Vorobiev V; Babič A; Crowe LA; Van De Looij Y; Lenglet S; Thomas A; Helm L; Vallée JP; Allémann E
Int J Pharm; 2019 Sep; 568():118496. PubMed ID: 31279053
[TBL] [Abstract][Full Text] [Related]
6. Preparation, characterization and in vivo assessment of Gd-albumin and Gd-dendrimer conjugates as intravascular contrast-enhancing agents for MRI.
Nwe K; Milenic D; Bryant LH; Regino CA; Brechbiel MW
J Inorg Biochem; 2011 May; 105(5):722-7. PubMed ID: 21463567
[TBL] [Abstract][Full Text] [Related]
7. Preparation and performance of biocompatible gadolinium polymer as liver-targeting magnetic resonance imaging contrast agent.
Hu T; Wan C; Zhan Y; Li X; Zheng Y
J Biosci Bioeng; 2024 Feb; 137(2):134-140. PubMed ID: 38195341
[TBL] [Abstract][Full Text] [Related]
8. Cyclen-based Gd
Rashid HU; Martines MAU; Jorge J; de Moraes PM; Umar MN; Khan K; Rehman HU
Bioorg Med Chem; 2016 Nov; 24(22):5663-5684. PubMed ID: 27729196
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of methotrexate-conjugated gadolinium(III) for cancer diagnosis and treatment.
Xu D; Lu ST; Li YS; Baidya A; Mei H; He Y; Wu B
Drug Des Devel Ther; 2018; 12():3301-3309. PubMed ID: 30323562
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and evaluation of globular Gd-DOTA-monoamide conjugates with precisely controlled nanosizes for magnetic resonance angiography.
Kaneshiro TL; Jeong EK; Morrell G; Parker DL; Lu ZR
Biomacromolecules; 2008 Oct; 9(10):2742-8. PubMed ID: 18771313
[TBL] [Abstract][Full Text] [Related]
11. Gadolinium(III)-loaded nanoparticulate zeolites as potential high-field MRI contrast agents: relationship between structure and relaxivity.
Csajbók E; Bányai I; Vander Elst L; Muller RN; Zhou W; Peters JA
Chemistry; 2005 Aug; 11(16):4799-807. PubMed ID: 15929138
[TBL] [Abstract][Full Text] [Related]
12. Renal functional contrast-enhanced magnetic resonance imaging: evaluation of a new rapid-clearance blood pool agent (p792) in sprague-dawley rats.
Mandry D; Pedersen M; Odille F; Robert P; Corot C; Felblinger J; Grenier N; Claudon M
Invest Radiol; 2005 May; 40(5):295-305. PubMed ID: 15829826
[TBL] [Abstract][Full Text] [Related]
13. A multiple gadolinium complex decorated fullerene as a highly sensitive T(1) contrast agent.
Wang L; Zhu X; Tang X; Wu C; Zhou Z; Sun C; Deng SL; Ai H; Gao J
Chem Commun (Camb); 2015 Mar; 51(21):4390-3. PubMed ID: 25676633
[TBL] [Abstract][Full Text] [Related]
14. Physical, chemical and biological evaluations of CMD-A2-Gd-DOTA. A new paramagnetic dextran polymer.
Corot C; Schaefer M; Beauté S; Bourrinet P; Zehaf S; Bénizé V; Sabatou M; Meyer D
Acta Radiol Suppl; 1997; 412():91-9. PubMed ID: 9240087
[TBL] [Abstract][Full Text] [Related]
15. Development of a Gd(III)-based receptor-induced magnetization enhancement (RIME) contrast agent for β-glucuronidase activity profiling.
Chen SH; Kuo YT; Singh G; Cheng TL; Su YZ; Wang TP; Chiu YY; Lai JJ; Chang CC; Jaw TS; Tzou SC; Liu GC; Wang YM
Inorg Chem; 2012 Nov; 51(22):12426-35. PubMed ID: 23116118
[TBL] [Abstract][Full Text] [Related]
16. Gd-DOTA, a potential MRI contrast agent. Current status of physicochemical knowledge.
Meyer D; Schaefer M; Bonnemain B
Invest Radiol; 1988 Sep; 23 Suppl 1():S232-5. PubMed ID: 3198351
[TBL] [Abstract][Full Text] [Related]
17. Gadolinium-1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid conjugate of arabinogalactan as a potential liver-targeting magnetic resonance imaging contrast agent.
Xiao Y; Xue R; You T; Li X; Pei F; Wang X; Lei H
Carbohydr Res; 2014 Aug; 395():9-14. PubMed ID: 24995911
[TBL] [Abstract][Full Text] [Related]
18. An intravascular MRI contrast agent based on Gd(DO3A-Lys) for tumor angiography.
Yang CT; Chandrasekharan P; He T; Poh Z; Raju A; Chuang KH; Robins EG
Biomaterials; 2014 Jan; 35(1):327-36. PubMed ID: 24138829
[TBL] [Abstract][Full Text] [Related]
19. A small MRI contrast agent library of gadolinium(III)-encapsulated supramolecular nanoparticles for improved relaxivity and sensitivity.
Chen KJ; Wolahan SM; Wang H; Hsu CH; Chang HW; Durazo A; Hwang LP; Garcia MA; Jiang ZK; Wu L; Lin YY; Tseng HR
Biomaterials; 2011 Mar; 32(8):2160-5. PubMed ID: 21167594
[TBL] [Abstract][Full Text] [Related]
20. Tumor Contrast Enhancement and Whole-Body Elimination of the Manganese-Based Magnetic Resonance Imaging Contrast Agent Mn-PyC3A.
Erstad DJ; Ramsay IA; Jordan VC; Sojoodi M; Fuchs BC; Tanabe KK; Caravan P; Gale EM
Invest Radiol; 2019 Nov; 54(11):697-703. PubMed ID: 31356382
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
